Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TPST

Tempest Therapeutics Inc

May 08 • 04:00PM ET

1.99

+0.02 1.02 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NVCT CUE BLRX IMNN VERU

| Held by: VXF VTI DCOR DFAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-6.84	Insider Own	43.33%	Shs Outstand	14.34M	Perf Week	-2.45%
Market Cap	28.55M	Forward P/E	-	EPS next Y	-1.21	Insider Trans	3.87%	Shs Float	8.13M	Perf Month	25.95%
Enterprise Value	28.98M	PEG	-	EPS next Q	-0.28	Inst Own	3.29%	Short Float	7.88%	Perf Quarter	-17.08%
Income	-26.26M	P/S	-	EPS this Y	78.83%	Inst Trans	11.60%	Short Ratio	3.23	Perf Half Y	-80.00%
Sales	0.00M	P/B	1.47	EPS next Y	9.70%	ROA	-83.17%	Short Interest	0.64M	Perf YTD	-30.66%
Book/sh	1.35	P/C	3.70	EPS next 5Y	48.00%	ROE	-203.63%	52W High	12.23 -83.73%	Perf Year	-70.95%
Cash/sh	0.54	P/FCF	-	EPS past 3/5Y	46.00% 76.03%	ROIC	-192.86%	52W Low	1.50 32.67%	Perf 3Y	-92.53%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.89% 11.07%	Perf 5Y	-99.06%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	65.02%	Oper. Margin	-	ATR (14)	0.17	Perf 10Y	-99.99%
Dividend Ex-Date	-	Quick Ratio	2.50	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.81	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	2.50	EPS Q/Q	80.02%	SMA20	1.32%	Beta	-1.74	Target Price	11.00
Payout	-	Debt/Eq	1.22	Sales Q/Q	-	SMA50	0.25%	Rel Volume	0.41	Prev Close	1.97
Employees	4	LT Debt/Eq	1.04	Earnings	Mar 30 BMO	SMA200	-63.71%	Avg Volume	198.14K	Price	1.99
IPO	Nov 12, 2012	Option/Short	No / Yes	EPS/Sales Surpr.	50.00% -	Trades		Volume	81,021	Change	1.02%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)